Producer of cellulose products for the health science industry, JRS Pharma has added Celonic to its portfolio of products and services.

Celonic is a contract development and manufacturing organisation (CDMO) offering comprehensive development and manufacturing services for biotherapeutics. These services include the development of high yield production cell lines, efficient up-stream and down-stream processes, full good manufacturing practice (GMP) analytics, and the manufacture of active pharmaceutical ingredients (API) in cell culture systems at different scales of up to 1000l.

In addition, Celonic licenses its proprietary serum free expression (SEFEX) cell line technology to clients, drug developers, and other service providers.

Celonic offers a wide range of biopharma services and expertise for new biological entities, biosimilars, and cell lines.